WHO WE ARE
Our Mission: Enabling Better Healthcare
Our mission is to offer patients the best possible medical treatment through intelligent software solutions.
Our mission is to offer patients the best possible medical treatment through intelligent software solutions.
Climedo is the leading all-in-one eCOA and EDC platform for real-world and late-phase clinical studies. Powered by Autonomous Data Capture, study data flows in from the source with near-zero manual entry, delivering real-time insights on efficacy and safety directly to HCPs and KOLs. Founded in Munich in 2017, trusted by pharma, medtech, CROs and academia, over 2 million patients enrolled across 200+ studies to date.
This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster.
Climedo was founded in Munich in 2017 by physicians who spent years in clinical research. We experienced firsthand the pain of manual data entry, site recruitment challenges and regulatory pressure. We saw how legacy EDC systems slowed studies down and created friction at every step. That is why we built a platform that removes this friction, starting with Autonomous Data Capture.
By 2028, Climedo will eliminate manual data entry for at least 50% of eligible fields. No EDC vendor has a credible roadmap to match this. It is the inflection point, where data flows from source to EDC without human intermediaries. Autonomous Data Capture is not a feature. It is the creation of a new category.
At least 50% of eligible fields automated by 2028.
Scientific dialogue during ongoing studies.
Study setup in 3 to 5 days instead of 3 to 4 weeks.
Guided by our From Data to Dialogue whitepaper.
Climedo's culture is built on ambition, empathy and confidence. We celebrate success but stay grounded, and we are constantly evolving. Our innovation engine, embodied by AI Study Configurator (our AI-first employee), lets us ship AI features faster than any competitor. We are not building for the eClinical market of today. We are building for 2030.
Co-Founder and CEO
Co-Founder and CTO
Co-Founder
